Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Additional patients and extended follow-up from BRUIN Meeting Abstract


Authors: Munir, T.; Mato, A. R.; Woyach, J. A.; Brown, J. R.; Ghia, P.; Patel, K.; Eyre, T. A.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; Seymour, J. F.; Shah, N. N.; Coombs, C. C.; Ujjani, C. S.; Patel, M. R.; Fakhri, B.; Cheah, C. Y.; Alencar, A. J.; Cohen, J. B.; Gerson, J. N.; Flinn, I. W.; Ma, S.; Jagadeesh, D.; Rhodes, J. M.; Hernandez-Ilizaliturri, F.; Zinzani, P. L.; Balbas, M.; Nair, B.; Abada, P.; Wang, C.; Wang, D.; Tsai, D. E.; Wierda, W. G.; Jurczak, W.
Abstract Title: Pirtobrutinib efficacy in covalent BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Additional patients and extended follow-up from BRUIN
Meeting Title: 63rd Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 201
Issue: Suppl. 1
Meeting Dates: 2023 Apr 23-25
Meeting Location: Birmingham, United Kingdom
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2023-04-01
Start Page: 110
End Page: 111
Language: English
ACCESSION: WOS:001049283000181
PROVIDER: wos
DOI: 10.1111/bjh.18720
Notes: Meeting Abstract: BSH23- PO84 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato